幹細胞製造市場：2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測

到 2022 年，全球幹細胞製造市場將達到 123 億美元。 展望未來，IMARC Group 預測到 2028 年將達到 199 億美元，顯示 2023 年至 2028 年之間的增長率 (CAGR) 為 8.1%。

幹細胞是構成動植物組織器官的未分化或部分分化的細胞。 幹細胞通常來源於血液、骨髓、臍帶、胚胎和胎盤。 在體內和實驗室的適當條件下，幹細胞可以分裂形成紅細胞、血小板和白細胞等細胞，並發揮特殊功能。 幹細胞廣泛用於人類疾病模型、藥物發現、無法治癒疾病的細胞療法開發、基因療法和組織工程。 幹細胞被冷凍保存以維持活力並最大限度地減少遺傳改變，因此用於替換受損的器官和組織並治療各種疾病。

幹細胞製造市場趨勢

• 隨著人們對乾細胞治療潛力的認識不斷提高，風險投資 (VC) 對乾細胞研究的投資不斷增加，這主要推動了全球市場的發展。 除此之外，該產品在有效疾病管理、個性化醫療和基因組檢測等應用中的廣泛使用也對市場增長產生了積極影響。 此外，採用三維 (3D) 打印和微流體技術將多個生產過程集成到一個設備中以縮短生產時間和降低成本也在推動市場增長。 此外，製藥行業越來越多地使用產品來製造用於治療腫瘤、白血病和淋巴瘤的造血幹細胞 (HSC) 和間充質乾細胞 (MSC) 藥物，這將成為另一個增長動力。 此外，該產品在研究應用中越來越多地用於創造新藥以改善功能或幫助疾病進展，也顯著推動了市場。 預計將推動市場的其他因素包括技術在組織和器官替代療法中的應用越來越多、醫療基礎設施的顯著改善以及政府為促進公眾健康而採取的各種措施的實施。

主要市場細分

• IMARC Group 分析了全球幹細胞製造市場報告每個子部分的主要趨勢，以及 2023 年至 2028 年全球、區域和國家層面的預測。 該報告根據產品、應用和最終用戶對市場進行分類。

按產品細分

• 消耗品
• 培養基
• 其他
• 樂器
• 生物反應器、培養箱
• 細胞分選員
• 其他
• 幹細胞系
• 造血幹細胞 (HSC)
• 間充質乾細胞 (MSC)
• 誘導多能幹細胞 (iPSC)
• 胚胎幹細胞 (ESC)
• 神經乾細胞 (NSC)
• 多能成體祖細胞

按應用細分

• 研究用途
• 生命科學研究
• 藥物發現和藥物開發
• 臨床應用
• 同種異體幹細胞療法
• 自體幹細胞療法
• 細胞/組織庫申請

最終用戶細分

• 製藥和生物技術公司
• 學術機構、研究機構、合同研究機構
• 醫院和手術中心
• 細胞/組織庫
• 其他

按地區劃分

• 北美
• 美國
• 加拿大
• 亞太地區
• 中國
• 日本
• 印度
• 韓國
• 澳大利亞
• 印度尼西亞
• 其他
• 歐洲
• 德國
• 法國
• 英國
• 意大利
• 西班牙
• 俄羅斯
• 其他
• 拉丁美洲
• 巴西
• 墨西哥
• 其他
• 中東和非洲

本報告中回答的關鍵問題

• 1.2022年全球幹細胞製造市場規模有多大？
• 2.2023-2028年全球幹細胞製造市場的預期增長率是多少？
• 3. 推動全球幹細胞製造市場的關鍵因素是什麼？
• 4.COVID-19 對全球幹細胞製造市場有何影響？
• 5. 按產品劃分的全球幹細胞製造市場是怎樣的？
• 6. 按應用細分的干細胞製造全球市場是怎樣的？
• 7. 全球幹細胞製造市場的最終用戶細分情況如何？
• 8. 全球幹細胞製造市場的主要區域有哪些？
• 9.9. 全球幹細胞製造市場的主要參與者/公司有哪些？

內容

第一章前言

第 2 章研究方法和範圍

• 調查的目的
• 利益相關者
• 數據源
  • 主要信息
  • 次要信息
• 市場評估
  • 自下而上的方法
  • 自上而下的方法
• 預測方法

第 3 章執行摘要

第四章介紹

• 概覽
• 主要行業趨勢

第 5 章全球幹細胞製造市場

• 市場概覽
• 市場結果
• COVID-19 的影響
• 市場預測

第 6 章按產品劃分的市場細分

• 消耗品
  • 市場趨勢
  • 主要細分市場
    • 培養基
    • 其他
  • 市場預測
• 儀器
  • 市場趨勢
  • 主要細分市場
    • 生物反應器和培養箱
    • 細胞分選員
    • 其他
  • 市場預測
• 幹細胞系
  • 市場趨勢
  • 主要細分市場
    • 造血幹細胞 (HSC)
    • 間充質乾細胞 (MSC)
    • 誘導多能幹細胞 (iPSC)
    • 胚胎幹細胞 (ESC)
    • 神經乾細胞 (NSC)
    • 多能成體祖細胞
  • 市場預測

第 7 章應用市場細分

• 調查的申請
  • 市場趨勢
  • 主要細分市場
    • 生命科學研究
    • 藥物發現和藥物開發
  • 市場預測
• 臨床應用
  • 市場趨勢
  • 主要細分市場
    • 同種異體幹細胞療法
    • 自體幹細胞療法
  • 市場預測
• 細胞和組織庫應用
  • 市場趨勢
  • 市場預測

第 8 章最終用戶市場細分

• 製藥和生物技術公司
  • 市場趨勢
  • 市場預測
• 學術機構、研究機構、合同研究機構
  • 市場趨勢
  • 市場預測
• 醫院、手術中心
  • 市場趨勢
  • 市場預測
• 細胞/組織庫
  • 市場趨勢
  • 市場預測
• 其他
  • 市場趨勢
  • 市場預測

第 9 章按區域劃分的市場細分

• 北美
  • 美國
    • 市場趨勢
    • 市場預測
  • 加拿大
    • 市場趨勢
    • 市場展望
• 亞太地區
  • 中國
    • 市場趨勢
    • 市場展望
  • 日本
    • 市場趨勢
    • 市場預測
  • 印度
    • 市場趨勢
    • 市場展望
  • 韓國市場
    • 市場趨勢
    • 市場展望
  • 澳大利亞
    • 市場趨勢
    • 市場展望
  • 印度尼西亞
    • 市場趨勢
    • 市場展望
  • 其他
    • 市場趨勢
    • 市場預測
• 歐洲
  • 德國
    • 市場趨勢
    • 市場展望
  • 法國
    • 市場趨勢
    • 市場預測
  • 英國
    • 市場趨勢
    • 市場預測
  • 意大利
    • 市場趨勢
    • 市場展望
  • 西班牙
    • 市場趨勢
    • 市場展望
  • 俄羅斯
    • 市場趨勢
    • 市場展望
  • 其他
    • 市場趨勢
    • 市場預測
• 拉丁美洲
  • 巴西
    • 市場趨勢
    • 市場展望
  • 墨西哥
    • 市場趨勢
    • 市場展望
  • 其他
    • 市場趨勢
    • 市場預測
• 中東和非洲
  • 市場趨勢
  • 按國家/地區劃分的市場細分
  • 市場展望

第 10 章 SWOT 分析

• 概覽
• 強度
• 弱點
• 機會
• 威脅

第11章價值鏈分析

第12章搬運工五力分析

• 概覽
• 買家的議價能力
• 供應商的議價能力
• 競爭程度
• 新進入者的威脅
• 替代品的威脅

第 13 章：價格分析

第14章競爭格局

• 市場結構
• 主要公司
• 主要公司簡介
  • Anterogen Co. Ltd.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Corporation
  • Corning Incorporated
  • FUJIFILM Holdings Corporation
  • Lonza Group AG
  • Merck KGaA
  • Sartorius AG
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

The global stem cell manufacturing market size reached US$ 12.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

Stem cells are undifferentiated or partially differentiated cells that make up the tissues and organs of animals and plants. They are commonly sourced from blood, bone marrow, umbilical cord, embryo, and placenta. Under the right body and laboratory conditions, stem cells can divide to form more cells, such as red blood cells (RBCs), platelets, and white blood cells, which generate specialized functions. They are widely used for human disease modeling, drug discovery, development of cell therapies for untreatable diseases, gene therapy, and tissue engineering. Stem cells are cryopreserved to maintain their viability and minimize genetic change and are consequently used later to replace damaged organs and tissues and treat various diseases.

Stem Cell Manufacturing Market Trends:

• The global market is primarily driven by the increasing venture capital (VC) investments in stem cell research due to the rising awareness about the therapeutic potency of stem cells. Apart from this, the widespread product utilization in effective disease management, personalized medicine, and genome testing applications are favoring the market growth. Additionally, the incorporation of three-dimensional (3D) printing and microfluidic technologies to reduce production time and lower cost by integrating multiple production steps into one device is providing an impetus to the market growth. Furthermore, the increasing product utilization in the pharmaceutical industry for manufacturing hematopoietic stem cells (HSC)- and mesenchymal stem cells (MSC)-based drugs for treating tumors, leukemia, and lymphoma is acting as another growth-inducing factor. Moreover, the increasing product application in research applications to produce new drugs that assist in improving functions and altering the progress of diseases is providing a considerable boost to the market. Other factors, including the increasing usage of the technique in tissue and organ replacement therapies, significant improvements in medical infrastructure, and the implementation of various government initiatives promoting public health, are anticipated to drive the market.

Key Market Segmentation:

• IMARC Group provides an analysis of the key trends in each sub-segment of the global stem cell manufacturing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

• Consumables
• Culture Media
• Others
• Instruments
• Bioreactors and Incubators
• Cell Sorters
• Others
• Stem Cell Lines
• Hematopoietic Stem Cells (HSC)
• Mesenchymal Stem Cells (MSC)
• Induced Pluripotent Stem Cells (iPSC)
• Embryonic Stem Cells (ESC)
• Neural Stem Cells (NSC)
• Multipotent Adult Progenitor Stem Cells

Breakup by Application:

• Research Applications
• Life Science Research
• Drug Discovery and Development
• Clinical Application
• Allogenic Stem Cell Therapy
• Autologous Stem Cell Therapy
• Cell and Tissue Banking Applications

Breakup by End User:

• Pharmaceutical & Biotechnology Companies
• Academic Institutes, Research Laboratories and Contract Research Organizations
• Hospitals and Surgical Centers
• Cell and Tissue banks
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

• The competitive landscape of the industry has also been examined along with the profiles of the key players being Anterogen Co. Ltd., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Corning Incorporated, FUJIFILM Holdings Corporation, Lonza Group AG, Merck KGaA, Sartorius AG, Takara Bio Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

• 1. What was the size of the global stem cell manufacturing market in 2022?
• 2. What is the expected growth rate of the global stem cell manufacturing market during 2023-2028?
• 3. What are the key factors driving the global stem cell manufacturing market?
• 4. What has been the impact of COVID-19 on the global stem cell manufacturing market?
• 5. What is the breakup of the global stem cell manufacturing market based on product?
• 6. What is the breakup of the global stem cell manufacturing market based on the application?
• 7. What is the breakup of the global stem cell manufacturing market based on the end user?
• 8. What are the key regions in the global stem cell manufacturing market?
• 9. Who are the key players/companies in the global stem cell manufacturing market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Stem Cell Manufacturing Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Consumables
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Culture Media
    • 6.1.2.2 Others
  • 6.1.3 Market Forecast
• 6.2 Instruments
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Bioreactors and Incubators
    • 6.2.2.2 Cell Sorters
    • 6.2.2.3 Others
  • 6.2.3 Market Forecast
• 6.3 Stem Cell Lines
  • 6.3.1 Market Trends
  • 6.3.2 Key Segments
    • 6.3.2.1 Hematopoietic Stem Cells (HSC)
    • 6.3.2.2 Mesenchymal Stem Cells (MSC)
    • 6.3.2.3 Induced Pluripotent Stem Cells (iPSC)
    • 6.3.2.4 Embryonic Stem Cells (ESC)
    • 6.3.2.5 Neural Stem Cells (NSC)
    • 6.3.2.6 Multipotent Adult Progenitor Stem Cells
  • 6.3.3 Market Forecast

7 Market Breakup by Application

• 7.1 Research Applications
  • 7.1.1 Market Trends
  • 7.1.2 Key Segments
    • 7.1.2.1 Life Science Research
    • 7.1.2.2 Drug Discovery and Development
  • 7.1.3 Market Forecast
• 7.2 Clinical Application
  • 7.2.1 Market Trends
  • 7.2.2 Key Segments
    • 7.2.2.1 Allogenic Stem Cell Therapy
    • 7.2.2.2 Autologous Stem Cell Therapy
  • 7.2.3 Market Forecast
• 7.3 Cell and Tissue Banking Applications
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Pharmaceutical & Biotechnology Companies
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Academic Institutes, Research Laboratories and Contract Research Organizations
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Hospitals and Surgical Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Cell and Tissue banks
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Anterogen Co. Ltd.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
  • 14.3.2 Becton Dickinson and Company
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Bio-Rad Laboratories Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Bio-Techne Corporation
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
  • 14.3.5 Corning Incorporated
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 FUJIFILM Holdings Corporation
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
  • 14.3.7 Lonza Group AG
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Merck KGaA
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
  • 14.3.9 Sartorius AG
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
  • 14.3.10 Takara Bio Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
  • 14.3.11 Thermo Fisher Scientific Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis

List of Figures

• Figure 1: Global: Stem Cell Manufacturing Market: Major Drivers and Challenges
• Figure 2: Global: Stem Cell Manufacturing Market: Sales Value (in Billion US$), 2017-2022
• Figure 3: Global: Stem Cell Manufacturing Market Forecast: Sales Value (in Billion US$), 2023-2028
• Figure 4: Global: Stem Cell Manufacturing Market: Breakup by Product (in %), 2022
• Figure 5: Global: Stem Cell Manufacturing Market: Breakup by Application (in %), 2022
• Figure 6: Global: Stem Cell Manufacturing Market: Breakup by End User (in %), 2022
• Figure 7: Global: Stem Cell Manufacturing Market: Breakup by Region (in %), 2022
• Figure 8: Global: Stem Cell Manufacturing (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 9: Global: Stem Cell Manufacturing (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 10: Global: Stem Cell Manufacturing (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 11: Global: Stem Cell Manufacturing (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 12: Global: Stem Cell Manufacturing (Stem Cell Lines) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 13: Global: Stem Cell Manufacturing (Stem Cell Lines) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 14: Global: Stem Cell Manufacturing (Research Applications) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 15: Global: Stem Cell Manufacturing (Research Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 16: Global: Stem Cell Manufacturing (Clinical Application) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 17: Global: Stem Cell Manufacturing (Clinical Application) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 18: Global: Stem Cell Manufacturing (Cell and Tissue Banking Applications) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 19: Global: Stem Cell Manufacturing (Cell and Tissue Banking Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 20: Global: Stem Cell Manufacturing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 21: Global: Stem Cell Manufacturing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 22: Global: Stem Cell Manufacturing (Academic Institutes, Research Laboratories and Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 23: Global: Stem Cell Manufacturing (Academic Institutes, Research Laboratories and Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 24: Global: Stem Cell Manufacturing (Hospitals and Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 25: Global: Stem Cell Manufacturing (Hospitals and Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 26: Global: Stem Cell Manufacturing (Cell and Tissue banks) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 27: Global: Stem Cell Manufacturing (Cell and Tissue banks) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 28: Global: Stem Cell Manufacturing (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 29: Global: Stem Cell Manufacturing (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 30: North America: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 31: North America: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 32: United States: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 33: United States: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 34: Canada: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 35: Canada: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 36: Asia-Pacific: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 37: Asia-Pacific: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 38: China: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 39: China: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 40: Japan: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 41: Japan: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 42: India: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 43: India: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 44: South Korea: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 45: South Korea: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 46: Australia: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 47: Australia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 48: Indonesia: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 49: Indonesia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 50: Others: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 51: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 52: Europe: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 53: Europe: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 54: Germany: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 55: Germany: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 56: France: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 57: France: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 58: United Kingdom: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 59: United Kingdom: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 60: Italy: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 61: Italy: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 62: Spain: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 63: Spain: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 64: Russia: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 65: Russia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 66: Others: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 67: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 68: Latin America: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 69: Latin America: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 70: Brazil: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 71: Brazil: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 72: Mexico: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 73: Mexico: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 74: Others: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 75: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 76: Middle East and Africa: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 77: Middle East and Africa: Stem Cell Manufacturing Market: Breakup by Country (in %), 2022
• Figure 78: Middle East and Africa: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 79: Global: Stem Cell Manufacturing Industry: SWOT Analysis
• Figure 80: Global: Stem Cell Manufacturing Industry: Value Chain Analysis
• Figure 81: Global: Stem Cell Manufacturing Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Stem Cell Manufacturing Market: Key Industry Highlights, 2022 and 2028
• Table 2: Global: Stem Cell Manufacturing Market Forecast: Breakup by Product (in Million US$), 2023-2028
• Table 3: Global: Stem Cell Manufacturing Market Forecast: Breakup by Application (in Million US$), 2023-2028
• Table 4: Global: Stem Cell Manufacturing Market Forecast: Breakup by End User (in Million US$), 2023-2028
• Table 5: Global: Stem Cell Manufacturing Market Forecast: Breakup by Region (in Million US$), 2023-2028
• Table 6: Global: Stem Cell Manufacturing Market: Competitive Structure
• Table 7: Global: Stem Cell Manufacturing Market: Key Players